Table 1 Patient characteristics.
Characteristics | Patients, no. (%) N = 12 |
|---|---|
Age (median, range), years | 52 (37–71) |
Race/ethnicity | |
White | 7 (58.3%) |
ECOG performance status | |
0 | 8 (66.7%) |
1 | 4 (33.3%) |
ER and/or PR positive | 8 (66.7%) |
Number of metastatic sites (median, range) | 2 (1–5) |
Previous pertuzumab in any setting | 9 (75%) |
Previous T-DM1 in any setting | 7 (58.3%) |
Number of prior lines of therapy for metastatic disease (median, range) | 2 (0–3) |
